XML 42 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

NET EARNINGS (LOSS) PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2024
NET EARNINGS (LOSS) PER SHARE |
NET EARNINGS (LOSS) PER SHARE | NOTE 11 – NET EARNINGS (LOSS) PER SHARE Basic and diluted net earnings (loss) per share attributable to common stockholders were calculated as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Year Ended December 31,
(In thousands, except share data) | ​ | ​ | 2022 | ​ | ​ | 2023 | ​ | ​ | 2024
Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) for diluted calculation | ​ | $ | (14,927) | ​ | $ | 8,312 | ​ | $ | 2,932
Add: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Financial expenses of 2024 Notes* | ​ | ​ | ​ | ​ | ​ | (1,168) | ​ | ​ | 39
Net income (loss) for diluted calculation | ​ | $ | (14,927) | ​ | $ | 7,144 | ​ | $ | 2,971
Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average shares of Common Stock outstanding for basic calculation | ​ | ​ | 48,472,159 | ​ | ​ | 67,512,527 | ​ | ​ | 72,530,698
Weighted average dilutive effect of 2024 Notes | ​ | ​ | ​ | ​ | ​ | 13,335,430 | ​ | ​ | 7,667,323
Weighted average dilutive effect of stock options and restricted stock | ​ | ​ | ​ | ​ | ​ | 1,576,059 | ​ | ​ | 859,155
Weighted average shares of Common Stock outstanding for diluted calculation | ​ | ​ | 48,472,159 | ​ | ​ | 82,424,016 | ​ | ​ | 81,057,176
​ * Financial expenses on 2024 Notes consists of add back of financial expense incurred during the year and inclusion of make-whole interest payments that will be incurred upon conversion. Diluted loss per share do not include 34,097,716 shares of Common Stock underlying outstanding stock options, warrants and convertible notes of the Company for the year ended December 31, 2022 because the effect would be anti-dilutive. In the year ended December 31, 2023, the diluted earnings per share do not include 18,254,264 shares of Common Stock underlying outstanding warrants and stock options because the effect would be anti-dilutive. In the year ended December 31, 2024, the diluted earnings per share do not include 16,661,907 shares of Common Stock underlying outstanding warrants and stock options because the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration